A simple blood test developed by BC Cancer Agency and Vancouver Prostate Centre researchers may help determine treatment for prostate cancer in the near future

Date Posted: 
2014-08-13

A new blood test developed by researchers at the BC Cancer Agency and the Vancouver Prostate Centre is garnering international attention, and has the potential to improve the way a deadly form of prostate cancer, metastatic castration-resistant prostate cancer (CRPC), is treated.

Medical oncologist Dr. Kim Chi and his team have been able to detect prostate cancer DNA (genetic code circulating in the blood) in most patients with CRPC. When the DNA is analyzed it can provide information on the genetic programming of a particular person’s prostate cancer, which can help guide treatment decisions. Previously, the only way to genetically profile a person’s metastatic cancer was through a biopsy, which can be painful, difficult and have complications.

Knowing which type of prostate cancer a patient has can dictate which drug therapies will be most effective and which will be least effective, allowing doctors to be more precise with their treatment recommendations. In a recent study Dr. Chi and his colleagues evaluated whether the genetic profile of men’s prostate cancer would be responsive or not to the latest hormone therapies. They identified key irregularities, androgen receptor (hormone) amplification and the F876L AR mutation, as determining factors in whether prostate cancer responds to hormone therapy.  The blood test can potentially be used during treatment as well, to analyze changes over time and allow for an ongoing “personalized medicine” approach.

The results of Dr. Chi’s most recent study was presented at the American Society of Clinical Oncology (ASCO) international general meeting.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Terry Fox

Terry Fox Run - September 15, 2019

This year's Terry Fox Run takes place on Sunday September 15, in locations across Canada.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Monday, September 16, 2019

Drs Cox, Gleave and Goldenberg awarded Prostate Cancer Canada and Movember 2019 Discovery Grants

Drs Cox, Gleave and Goldenberg
Thursday, September 12, 2019

Drs. Wyatt and Sorensen receive 2019 UBC Faculty of Medicine Awards for Distinguished Achievement

Drs Wyatt and Sorensen
Tuesday, September 10, 2019

Drs. Sorensen, Ester and Huntsman elected to Royal Society of Canada

Drs Sorensen, Ester, Huntsman